InvestorsHub Logo
Followers 22
Posts 1717
Boards Moderated 0
Alias Born 10/22/2013

Re: Buddhahead post# 22253

Saturday, 02/28/2015 10:43:17 AM

Saturday, February 28, 2015 10:43:17 AM

Post# of 30990
Thanks for posting, Budda. Thought this exerpt from article was interesting, seems it's different from how AC works?

“MCC950 is able to be given orally and will be cheaper to produce than current protein-based treatments, which are given daily, weekly or monthly by injection,” he said. “Importantly, it will also have a shorter duration in the body, allowing clinicians to stop the anti-inflammatory action if the patient ever needed to switch their immune response back to 100 per cent in order to clear an infection.” Read more from Asian Scientist Magazine at: http://www.asianscientist.com/2015/02/in-the-lab/treatment-inflammatory-diseases/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.